质子驱动的可变性使纳米酶集成疫苗能够用于增强瘤免疫治疗
Jingyi An1,2, Yijie Yang1, Yiming Feng1
1Nanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Advanced materials (Deerfield Beach, Fla.)
|October 25, 2025
概括
这项研究引入了一种新型纳米疫苗 (PP@Pt-OVA),它向淋巴结,增强免疫应对癌症. 该纳米疫苗有效地抑制瘤生长和转移,毒性最小.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 使用疫苗的癌症免疫疗法显示出瘤回归和转移预防的前景.
- 设计有效的癌症疫苗是具有挑战性的,因为在淋巴结 (LN) 向,树突细胞 (DC) 吸收和细胞免疫激活方面存在困难.
研究的目的:
- 开发一种以质子驱动的多功能纳米疫苗 (PP@Pt-OVA),克服当前癌症疫苗设计的局限性.
- 增强LN向,DC吸收和细胞免疫激活,以改善癌症免疫治疗.
主要方法:
- 一种纳米疫苗 (PP@Pt-OVA) 是使用PVP@Pt纳米酶和OVA在PEG-b-PAE小粒中进行的.
- 该纳米疫苗利用在酸性LN环境中由质子驱动的形态变化来优化LN保留和DC吸收.
- 纳米酶催化产生反应性氧物种 (ROS),促进内体逃生,抗原交叉呈现和DC成熟.
主要成果:
- PP@Pt-OVA证明了有效的LN准和增强的直流吸收.
- 该纳米疫苗成功激活了CD8+ T细胞,并在预防性和治疗性黑色素瘤模型中抑制了瘤生长.
- PP@Pt-OVA表现出极好的生物相容性和最小的系统毒性.
结论:
- PP@Pt-OVA作为一个多功能纳米疫苗平台,有可能推进癌症免疫疗法.
- 理性设计框架解决了亚单元疫苗的局限性,为癌症治疗提供了一个有希望的策略.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
952
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
952
Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936


